Once the sensor reaches the stomach, it transmits a signal to a patch worn by the patient, and a digital record is sent to an app on the patient’s mobile device.

Results from Prevenir, an ongoing observational study, provided further evidence that on-demand PrEP is an effective strategy for preventing HIV acquisition in at-risk MSM.

This app provides mobile access to WHO PrEP Implementation Tool (WHO Implementation Tool for Pre-Exposure Prophylaxis of HIV Infection) and was developed to be a “digital pocket reference” available for clinicians and pharmacists. WHO has developed a series of modules to support the implementation of PrEP ...

Gilead announces new data on the impact of Truvada® (emtricitabine and tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) on the number of HIV diagnoses in the United States.

Strategies to reduce new HIV infections span multifaceted efforts, including safe-sex counseling, voluntary medical male circumcision, treatment as prevention, and pre- (PrEP) and postexposure prophylaxis. PrEP entails the use of antiretroviral (ARV) drugs prophylactically by HIV-negative individuals at risk of infection to thwart acquisition of ...

In February 2018, the first European PrEP event "PrEP In Europe Summit 2018" took place in Amsterdam, uniting over 100 activists. Despite the numerous delegations from Eastern Europe and Central Asia attending the event, few people know about the opportunities offered by PrEP in our ...

Within the framework of the meeting, the Consortium leaders presented the National Action Plan of the Estonian Communities for 2017-2020 (National Plan) − a strategic document developed in cooperation with representatives of all KAP of the country. It should be noted that the main purpose ...

Today the XVI European AIDS Conference hosts a separate session on PrEP in Europe. Right now you can join the session online on Facebook or view its record here: “This year, the XVI European AIDS Conference puts special emphasis on the group “women living with HIV”, a range of sessions and discussions on the contemporary PrEP methodologies, new test methods and drugs interaction. A lot of information presented about the co-infection: how to treat it correctly, comparison of ...

HIV infections continue to occur at a rate of >2 million globally each year with women accounting for a little over 50% of infections. Although the overall incidence of HIV infections in the United States has decreased in recent years, certain populations remain particularly vulnerable, including racial/ethnic ...

Conference funders, Gilead Sciences, named and shamed for its “insatiable greed” 9th International AIDS Conference on HIV Science in Paris (IAS 2017), drew to a close, in style. The community address delivered by Othoman Mellouk, during the final ceremony, exposed one of the key conference sponsors, ...

AIDES and PLUS announced to conference attendees from the world over results from the biggest European survey ever to be conducted regarding knowledge, interest and utilisation of PrEP, Flash! PrEP in Europe. This presentation revealed the principal barriers, both individual and structural, regarding access to this ...

Key HIV drugs added to the list of medicines critical to public health, including tenofovir for HIV prevention, and dolutegravir. Earlier this month, the World Health Organization (WHO) updated their list of medicines deemed ‘essential’ as part of a well-functioning health system. That is, the drugs ...

This year, pre-exposure prophylaxis (PrEP) advocates noted a stunning disconnect between key organizations that issue guidelines on the use of tenofovir/emtricitabine (TDF/FTC, Truvada) for HIV prevention: The United States Centers for Disease Control and Prevention (CDC) continues to say that people need 20 days of ...

Please read and share the letter signed by EATG, as Europe’s transnational HIV treatment and prevention advocacy group, and the PrEP in Europe Initiative (PEI), a partnership of European prevention and policy NGOs, requesting Gilead Sciences to make it possible for Truvada®, or for generic equivalents of ...

Face-to-face interventions work best A meta-analysis of studies of brief interventions to reduce HIV risk behaviour in HIV-negative gay men has concluded that there is evidence that such techniques did have a significant impact on the behaviours they were designed to change. It also found evidence that ...

The number of new HIV diagnoses in gay men attending five key London clinics fell substantially during 2015 and 2016, Valerie Delpech of Public Health England told the British HIV Association (BHIVA) conference in Liverpool yesterday. Epidemiological analysis shows that the phenomenon is real. Diagnoses fell ...

An international group of researchers involved in the ANRS 12174 randomised controlled trial of pre-exposure prophylaxis (PrEP) for infants say that it is high time we started giving PrEP to all breastfed babies of HIV-positive mothers in countries where the likelihood of transmission via breastfeeding ...